Literature DB >> 1385479

Expression and localization of proteins of the complement system in human skin.

N Dovezenski1, R Billetta, I Gigli.   

Abstract

The complement system participates in the immune recognition of foreign antigens, many of which may penetrate the skin by physical injury or transcutaneous adsorption. In this study, we examined the presence of complement components and complement regulatory proteins in the human skin and cultured human keratinocytes. Immunofluorescence studies showed C3, Factor B, decay accelerating factor, the C3b receptor (CR1), and C3d receptor (CR2), distributed among cells of the epidermis as well as on cultured keratinocytes. Immunoblot analysis of keratinocytes supernatants showed the presence of C3 with a molecular weight of approximately 180 kD. The decay accelerating factor was localized as previously reported on elastic fibers; additionally it was observed in the basement membrane zone. In situ hybridization studies suggest the expression of CR1 and CR2 mRNA in human epidermis. These results show the presence in the human epidermis of complement components that are capable of generating the initial C3 convertase of the alternative pathway. The presence of complement regulatory proteins could endow keratinocytes with immune functions such as the regulation of complement activation and endocytosis of C3 opsonized particles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385479      PMCID: PMC443264          DOI: 10.1172/JCI116080

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

Authors:  J S Greenspan; D Greenspan; E T Lennette; D I Abrams; M A Conant; V Petersen; U K Freese
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

2.  The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation.

Authors:  T F Tedder; J J Weis; L T Clement; D T Fearon; M D Cooper
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

3.  Structure and functions of gp 140, the C3d/EBV receptor (CR2) of human B lymphocytes.

Authors:  R Frade
Journal:  Mol Immunol       Date:  1986-11       Impact factor: 4.407

4.  Growth control of activated, synchronized murine B cells by the C3d fragment of human complement.

Authors:  F Melchers; A Erdei; T Schulz; M P Dierich
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

5.  C3d,g is present in normal human epidermal basement membrane.

Authors:  N Basset-Seguin; M Dersookian; K Cehrs; K B Yancey
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

6.  Erythrophagocytosis in Kaposi's sarcoma in acquired immune deficiency syndrome.

Authors:  P Schenk
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1986       Impact factor: 1.538

7.  The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.

Authors:  T Fujita; T Inoue; K Ogawa; K Iida; N Tamura
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

8.  Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.

Authors:  G D Ross; M J Polley; E M Rabellino; H M Grey
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

9.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

10.  Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.

Authors:  L B Klickstein; T J Bartow; V Miletic; L D Rabson; J A Smith; D T Fearon
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  16 in total

1.  Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Authors:  Katerina Oikonomopoulou; Robert A DeAngelis; Hui Chen; Eleftherios P Diamandis; Morley D Hollenberg; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

2.  Complement factor I promotes progression of cutaneous squamous cell carcinoma.

Authors:  Pilvi Riihilä; Liisa Nissinen; Mehdi Farshchian; Atte Kivisaari; Risto Ala-Aho; Markku Kallajoki; Reidar Grénman; Seppo Meri; Sirkku Peltonen; Juha Peltonen; Veli-Matti Kähäri
Journal:  J Invest Dermatol       Date:  2014-09-03       Impact factor: 8.551

3.  A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1).

Authors:  A Repik; S E Pincus; I Ghiran; A Nicholson-Weller; D R Asher; A M Cerny; L S Casey; S M Jones; S N Jones; N Mohamed; L B Klickstein; G Spitalny; R W Finberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

4.  Staphylococcal proteases aid in evasion of the human complement system.

Authors:  Monika Jusko; Jan Potempa; Tomasz Kantyka; Ewa Bielecka; Halie K Miller; Magdalena Kalinska; Grzegorz Dubin; Peter Garred; Lindsey N Shaw; Anna M Blom
Journal:  J Innate Immun       Date:  2013-07-03       Impact factor: 7.349

Review 5.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

7.  Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.

Authors:  Anuja Java; M Kathryn Liszewski; Dennis E Hourcade; Fan Zhang; John P Atkinson
Journal:  Mol Immunol       Date:  2015-08-07       Impact factor: 4.407

8.  Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.

Authors:  Pilvi M Riihilä; Liisa M Nissinen; Risto Ala-Aho; Markku Kallajoki; Reidar Grénman; Seppo Meri; Sirkku Peltonen; Juha Peltonen; Veli-Matti Kähäri
Journal:  J Invest Dermatol       Date:  2013-08-12       Impact factor: 8.551

9.  Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance.

Authors:  C Hammerberg; S K Katiyar; M C Carroll; K D Cooper
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

10.  The complement system at the embryo implantation site: friend or foe?

Authors:  R Bulla; F Bossi; F Tedesco
Journal:  Front Immunol       Date:  2012-03-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.